A61L 2300/25
Peptides having up to 20 amino acids in a defined sequence
A61L2300/25 (Peptides having up to 20 amino acids in a defined sequence) appears on 239 US grants and 448 published applications in this corpus.
Search patents in A61L- Granted patents
- 239
- Published applications
- 448
- Assignees
- 289
- Inventors
- 1,030
- Latest grant
- 12 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 3 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 3 | 0 |
| 1995 | 5 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 3 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 0 | 1 |
| 2002 | 3 | 7 |
| 2003 | 2 | 5 |
| 2004 | 5 | 11 |
| 2005 | 3 | 8 |
| 2006 | 2 | 8 |
| 2007 | 3 | 14 |
| 2008 | 1 | 12 |
| 2009 | 7 | 23 |
| 2010 | 4 | 19 |
| 2011 | 12 | 21 |
| 2012 | 6 | 14 |
| 2013 | 8 | 16 |
| 2014 | 12 | 13 |
| 2015 | 20 | 37 |
| 2016 | 12 | 23 |
| 2017 | 19 | 27 |
| 2018 | 10 | 15 |
| 2019 | 13 | 30 |
| 2020 | 14 | 19 |
| 2021 | 12 | 27 |
| 2022 | 22 | 24 |
| 2023 | 6 | 23 |
| 2024 | 10 | 19 |
| 2025 | 9 | 17 |
| 2026 | 3 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Hard tissue therapeutics12 May 2026US 12,622,945 B2Orthotrophix, Inc.
- Regentide-041 and composition comprising Regentide-041 for improving skin condition21 Apr 2026US 12,606,595 B2Ninebiopharm Co., Ltd.
- Method to identify responders to osteoarthritis therapeutics6 Jan 2026US 12,514,900 B2Orthotrophix, Inc.
- Release of growth factors at wound healing stages2 Sep 2025US 12,403,179 B2Board of Trustees of the University of Arkansas
- Exosome bone graft systems, products and methods19 Aug 2025US 12,390,560 B2
- Magnesium phosphate for treatment of an infection20 Aug 2026US 2026/0241063 A1Bone Solutions, Inc.
- Endotoxin neutralising agent20 Aug 2026US 2026/0242413 A1Amferia AB
- Method to Identify Responders to Osteoarthritis Therapeutics30 Jul 2026US 2026/0216279 A1
- Cell-binding motifs (cbms) functionalized polymers23 Jul 2026US 2026/0207815 A1
- Peptide for cartilage regeneration, and uses thereof16 Jul 2026US 2026/0200987 A1Caregen Co., Ltd.
Most cited
By later US patents
- Biodegradable in-situ forming implants and methods of producing the same801US 4,938,763 A1990
- Stent sheath for local drug delivery435US 5,383,928 AEmory University · 1995
- Biodegradable in-situ forming implants and methods of producing the same374US 5,278,201 AAtrix Laboratories, Inc. · 1994
- Method of providing a substrate with a bio-active/biocompatible coating354US 5,869,127 ABoston Scientific Corporation · 1999
- Collagen wound healing matrices and process for their production341US 4,950,483 ACollagen Corporation · 1990